MARKET

ATAI

ATAI

Atai Beckley Inc
NASDAQ
3.540
+0.140
+4.12%
Pre Market: 3.608 +0.068 +1.91% 08:58 04/01 EDT
OPEN
3.455
PREV CLOSE
3.400
HIGH
3.610
LOW
3.450
VOLUME
7.28K
TURNOVER
--
52 WEEK HIGH
6.75
52 WEEK LOW
1.150
MARKET CAP
1.29B
P/E (TTM)
-1.2150
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATAI last week (0323-0327)?
Weekly Report · 2d ago
'Bipartisan Senators File Bill To Support Psychedelics Research And Treatment For Veterans' - Marijuana Moment
Benzinga · 4d ago
ATAI Life Sciences Price Target Announced at $12.00/Share by Deutsche Bank
Dow Jones · 4d ago
ATAI Life Sciences Initiated at Buy by Deutsche Bank
Dow Jones · 4d ago
Deutsche Bank Initiates Coverage On AtaiBeckley with Buy Rating, Announces Price Target of $12
Benzinga · 4d ago
ATAIBECKLEY INC <ATAI.O>: DEUTSCHE BANK INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $12
Reuters · 5d ago
AtaiBeckley initiated with a Buy at Deutsche Bank
TipRanks · 5d ago
U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex Holdings
Reuters · 5d ago
More
About ATAI
AtaiBeckley Inc is a clinical-stage biotechnology company focused on developing rapid-acting, durable and convenient mental health treatments. The Company’s pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 (R-MDMA HCI) for social anxiety disorder. The Company is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for opioid use disorder and TRD. BPL-003 is a proprietary synthetic intranasal formulation of mebufotenin benzoate being developed as a potential treatment for people living with TRD. VLS-01 is a proprietary oral transmucosal film formulation of N,N-Dimethyltryptamine (DMT) being developed as a potential treatment for people living with TRD. EMP-01 is an oral formulation of R-MDMA, being developed as a potential treatment for people living with social anxiety disorder.

Webull offers AtaiBeckley Inc stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.